Ambarella and Epizyme: breaking out or breaking bad?
The market-neutral spread of AMBA/EPZM broke out on Thursday (02/04/2015), in generally choppy trading conditions, showing clear signs of continuing its upward trend.
Up 4.67% for the day and closing near the high of its daily range, AMBA/EPZM shows good signs of posting sizeable gains over the coming months.
Ambarella is a semi-conductor stock that mainly serves the security and surveillance market and has seen a 162% increase in EPS since last quarter and a 62% increase sales over the same time period. It also has an annual ROE of just under 33% showing that management are making good use of their capital.
In comparison, Epizyme is a biomed/biotech stock that is bucking the strong sector performance trend by returning a decrease in EPS of -185% since last quarter and -72% in sales over the same time period. EPZM is definitely a laggard in a leading sector.
Anthony Walters 05/04/2015
Up 4.67% for the day and closing near the high of its daily range, AMBA/EPZM shows good signs of posting sizeable gains over the coming months.
Ambarella is a semi-conductor stock that mainly serves the security and surveillance market and has seen a 162% increase in EPS since last quarter and a 62% increase sales over the same time period. It also has an annual ROE of just under 33% showing that management are making good use of their capital.
In comparison, Epizyme is a biomed/biotech stock that is bucking the strong sector performance trend by returning a decrease in EPS of -185% since last quarter and -72% in sales over the same time period. EPZM is definitely a laggard in a leading sector.
Anthony Walters 05/04/2015
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.